USPH241220C150000
- 0.00
- 0.000.00%
US Physical Therapy Newsroom
US Physical Therapy Is Maintained at Outperform by Barrington Research
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
U.S. Physical Therapy's (NYSE:USPH) Conservative Accounting Might Explain Soft Earnings
Don't Ignore The Insider Selling In U.S. Physical Therapy
U.S. Physical Therapy to Present at the Stephens Annual Investment Conference and 16th Annual Southwest IDEAS Conference
Are Investors Undervaluing U.S. Physical Therapy, Inc. (NYSE:USPH) By 45%?
US Physical Therapy | 10-Q: Q3 2024 Earnings Report
Barrington Maintains US Physical Therapy(USPH.US) With Buy Rating, Maintains Target Price $108
Barrington Research Maintains Outperform on US Physical Therapy, Maintains $108 Price Target
US Physical Therapy Analyst Ratings
US Physical Therapy Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results.
BofA Securities Maintains US Physical Therapy(USPH.US) With Hold Rating
US Physical Therapy (USPH) Receives a Hold From Bank of America Securities
US Physical Therapy To Go Ex-Dividend On November 15th, 2024 With 0.44 USD Dividend Per Share
November 5th (Eastern Time) - $US Physical Therapy(USPH.US)$ is trading ex-dividend on November 15th, 2024.Shareholders of record on November 15th, 2024 will receive 0.44 USD dividend per share on
U.S. Physical Therapy (USPH) Q3 Earnings and Revenues Top Estimates
U.S. Physical Therapy Non-GAAP EPS of $0.55 Misses by $0.13, Revenue of $168.03M Beats by $3.65M
Earnings Flash (USPH) U.S. PHYSICAL THERAPY Posts Q3 Revenue $168M
Earnings Flash (USPH) U.S. PHYSICAL THERAPY Reports Q3 EPS $0.55
Express News | US Physical Therapy Q3 Dividend USD 0.44
Express News | US Physical Therapy Q3 Adjusted Ebitda USD 21.1 Million Vs. IBES Estimate USD 21 Million